Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Net Sales Growth

    Back to All Ratios
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

OXYGENTA PHARMACEUTICAL Last 5 Year Net Sales Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Net Sales Growth(%) 175.7127.93-48.8016.33279.30

What is the latest Net Sales Growth ratio of OXYGENTA PHARMACEUTICAL ?

The latest Net Sales Growth ratio of OXYGENTA PHARMACEUTICAL is 175.71 based on Mar2025 Standalone results.
Year Net Sales Growth
Mar2025175.71
Mar202427.93
Mar2023-48.80
Mar202216.33
Mar2021279.30

How is Net Sales Growth of OXYGENTA PHARMACEUTICAL Trending?

Years Net Sales Growth % Change
Mar2025 175.71
529.11
Mar2024 27.93
Positive
Mar2023 -48.8
Negative
Mar2022 16.33
-94.15
Mar2021 279.3 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare Net Sales Growth ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹187.0 Cr -2.8% -12.9% -37.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,195.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹169,849.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,586.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹109,054.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹108,703.0 Cr 1.3% 1.3% -9.4% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-2.8%

-12.9%

-37.8%

SENSEX

-1.7%

0.5%

8.3%


You may also like the below Video Courses